Hui Liu

Dr. Liu is the Founder and CEO of PrimaLux, a consulting firm specializing in pharmaceutical development. With over two decades of experience, Dr. Liu is an expert in formulating small molecules, RNAs, biologics, and gene therapies. He served as the Chief Technology Officer at Matinas Biopharma from 2020 to 2024. Prior to that, he was the Head of Formulation and Delivery at Seqirus, a global leader in influenza and pandemic response, where he spearheaded the development of lipid nanoparticle technology platforms for next-generation gene therapies. Earlier in his career, Dr. Liu held key roles at Cellics Therapeutics, Alcon (a Novartis spinoff), and Allergan (now part of AbbVie). He is a named inventor on 20 patents related to drug delivery technologies and biodegradable polymers. Dr. Liu holds a Ph.D. in Polymer Chemistry from the University of Michigan, an M.B.A. from the University of Massachusetts Amherst, and a B.S. from the University of  Science and Technology of China.